Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NicVAX for smoking cessation
NCT00836199Phase 3Completed
- Sponsor
- Nabi Biopharmaceuticals
- Start
- Oct 2009
- Primary completion
- Jul 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of NicVAX in Tobacco Use Disorder (TUD), sponsored by Nabi Biopharmaceuticals. Started Oct 2009; status: completed.
02
Drugs
NicVAX
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00836199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00836199.